Literature DB >> 26589779

Salvage therapy with pegylated liposomial doxorubicin-based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al.

Claudio Cerchione1, Mariano Lucignano1, Fabrizio Pane1, Lucio Catalano1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26589779     DOI: 10.1111/ejh.12705

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  3 in total

1.  Safety and comfort of domestic bortezomib injection in real-life experience.

Authors:  Claudio Cerchione; Davide Nappi; Anna Emanuele Pareto; Maria Di Perna; Irene Zacheo; Marco Picardi; Fabrizio Pane; Lucio Catalano
Journal:  Support Care Cancer       Date:  2018-03-24       Impact factor: 3.603

2.  Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma.

Authors:  Claudio Cerchione; Davide Nappi; Maria Di Perna; Irene Zacheo; Anna Emanuele Pareto; Marco Picardi; Lucio Catalano; Fabrizio Pane
Journal:  Case Rep Hematol       Date:  2016-10-27

3.  A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide.

Authors:  Claudio Cerchione; Davide Nappi; Maria Di Perna; Irene Zacheo; Ilaria Migliaccio; Dalila Salvatore; Marco Picardi; Fabrizio Pane; Lucio Catalano
Journal:  Clin Case Rep       Date:  2017-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.